Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Cohn DE, Brasky TM, Zaino R, Park K, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Randall ME, Brinton LA.

Am J Obstet Gynecol. 2018 Nov;219(5):459.e1-459.e11. doi: 10.1016/j.ajog.2018.08.002. Epub 2018 Aug 7.

PMID:
30096321
2.

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Brasky TM, Cohn DE, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel C, Boggess JF, Pearl ML, Ioffe OB, Deng W, Miller DS, Brinton LA.

Int J Cancer. 2018 Mar 15;142(6):1102-1115. doi: 10.1002/ijc.31127. Epub 2017 Nov 6.

3.

Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.

Holloway RW, Abu-Rustum NR, Backes FJ, Boggess JF, Gotlieb WH, Jeffrey Lowery W, Rossi EC, Tanner EJ, Wolsky RJ.

Gynecol Oncol. 2017 Aug;146(2):405-415. doi: 10.1016/j.ygyno.2017.05.027. Epub 2017 May 28. Review.

4.

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.

Creasman WT, Ali S, Mutch DG, Zaino RJ, Powell MA, Mannel RS, Backes FJ, DiSilvestro PA, Argenta PA, Pearl ML, Lele SB, Guntupalli SR, Waggoner S, Spirtos N, Boggess JF, Edwards RP, Filiaci VL, Miller DS.

Gynecol Oncol. 2017 Jun;145(3):519-525. doi: 10.1016/j.ygyno.2017.03.017. Epub 2017 Apr 6.

5.

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.

Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-10. doi: 10.1093/jnci/djw251.

6.

Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival.

Barber EL, Dusetzina SB, Stitzenberg KB, Rossi EC, Gehrig PA, Boggess JF, Garrett JM.

Gynecol Oncol. 2017 Jun;145(3):500-507. doi: 10.1016/j.ygyno.2017.03.014. Epub 2017 Mar 31.

7.

Robotic Radical Parametrectomy With Upper Vaginectomy and Pelvic Lymphadenectomy in Patients With Occult Cervical Carcinoma After Extrafascial Hysterectomy.

Tran AQ, Sullivan SA, Gehrig PA, Soper JT, Boggess JF, Kim KH.

J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):757-763. doi: 10.1016/j.jmig.2017.02.016. Epub 2017 Feb 22. Review.

PMID:
28254677
8.

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.

Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, Method M, Ade M, Ivanova A, Boggess JF.

Lancet Oncol. 2017 Mar;18(3):384-392. doi: 10.1016/S1470-2045(17)30068-2. Epub 2017 Feb 1.

PMID:
28159465
9.

Does the Robotic Platform Reduce Morbidity Associated With Combined Radical Surgery and Adjuvant Radiation for Early Cervical Cancers?

Clark LH, Barber EL, Gehrig PA, Soper JT, Boggess JF, Kim KH.

Int J Gynecol Cancer. 2016 Oct;26(8):1485-9. doi: 10.1097/IGC.0000000000000775.

10.

Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer.

Sert BM, Boggess JF, Ahmad S, Jackson AL, Stavitzski NM, Dahl AA, Holloway RW.

Eur J Surg Oncol. 2016 Apr;42(4):513-22. doi: 10.1016/j.ejso.2015.12.014. Epub 2016 Jan 21.

PMID:
26843445
11.

Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian Cancer.

Barber EL, Boggess JF, Van Le L, Kim KH, Bae-Jump VL, Brewster WR, Soper JT, Gehrig PA.

Obstet Gynecol. 2015 Dec;126(6):1191-7. doi: 10.1097/AOG.0000000000001138.

PMID:
26551182
12.

Obesity and perioperative pulmonary complications in robotic gynecologic surgery.

Wysham WZ, Kim KH, Roberts JM, Sullivan SA, Campbell SB, Roque DR, Moore DT, Gehrig PA, Boggess JF, Soper JT, Huh WK.

Am J Obstet Gynecol. 2015 Jul;213(1):33.e1-33.e7. doi: 10.1016/j.ajog.2015.01.033. Epub 2015 Jan 28.

PMID:
25637843
13.

Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk?

Doll KM, Snavely AC, Kalinowski A, Irwin DE, Bensen JT, Bae-Jump V, Boggess JF, Soper JT, Brewster WR, Gehrig PA.

Gynecol Oncol. 2014 Jun;133(3):546-51. doi: 10.1016/j.ygyno.2014.04.002. Epub 2014 Apr 12.

14.

Detection of sentinel nodes for endometrial cancer with robotic assisted fluorescence imaging: cervical versus hysteroscopic injection.

Rossi EC, Jackson A, Ivanova A, Boggess JF.

Int J Gynecol Cancer. 2013 Nov;23(9):1704-11. doi: 10.1097/IGC.0b013e3182a616f6.

PMID:
24177256
15.

Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients.

Doll KM, Stine JE, Van Le L, Moore DT, Bae-Jump V, Brewster WR, Soper JT, Boggess JF, Gehrig PA, Kim KH.

Gynecol Oncol. 2013 Jul;130(1):152-5. doi: 10.1016/j.ygyno.2013.03.020. Epub 2013 Mar 29.

PMID:
23542684
16.

Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells.

Zhou C, Steplowski TA, Dickens HK, Malloy KM, Gehrig PA, Boggess JF, Bae-Jump VL.

PLoS One. 2013;8(2):e55730. doi: 10.1371/journal.pone.0055730. Epub 2013 Feb 7.

17.

Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinoma.

Kilgore JE, Jackson AL, Ko EM, Soper JT, Van Le L, Gehrig PA, Boggess JF.

Gynecol Oncol. 2013 Apr;129(1):49-53. doi: 10.1016/j.ygyno.2012.12.020. Epub 2012 Dec 20.

PMID:
23262377
18.

Robotic resection of adnexal masses during pregnancy.

Eichelberger KY, Cantrell LA, Balthazar U, Boggess KA, Strauss RA, Boggess JF.

Am J Perinatol. 2013 May;30(5):371-5. doi: 10.1055/s-0032-1324705. Epub 2012 Aug 14.

PMID:
22893553
19.

Physical strain and urgent need for ergonomic training among gynecologic oncologists who perform minimally invasive surgery.

Franasiak J, Ko EM, Kidd J, Secord AA, Bell M, Boggess JF, Gehrig PA.

Gynecol Oncol. 2012 Sep;126(3):437-42. doi: 10.1016/j.ygyno.2012.05.016. Epub 2012 May 18.

PMID:
22613351
20.

Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers.

Fader AN, Seamon LG, Escobar PF, Frasure HE, Havrilesky LA, Zanotti KM, Secord AA, Boggess JF, Cohn DE, Fowler JM, Skafianos G, Rossi E, Gehrig PA.

Gynecol Oncol. 2012 Aug;126(2):180-5. doi: 10.1016/j.ygyno.2012.04.028. Epub 2012 Apr 30.

PMID:
22555102
21.

Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force.

Ramirez PT, Adams S, Boggess JF, Burke WM, Frumovitz MM, Gardner GJ, Havrilesky LJ, Holloway R, Lowe MP, Magrina JF, Moore DH, Soliman PT, Yap S.

Gynecol Oncol. 2012 Feb;124(2):180-4. doi: 10.1016/j.ygyno.2011.11.006. Epub 2011 Nov 10. No abstract available.

PMID:
22079679
22.

Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: a feasibility study.

Rossi EC, Ivanova A, Boggess JF.

Gynecol Oncol. 2012 Jan;124(1):78-82. doi: 10.1016/j.ygyno.2011.09.025. Epub 2011 Oct 11.

PMID:
21996262
23.

Management of a persistent adnexal mass in pregnancy: what is the ideal surgical approach?

Balthazar U, Steiner AZ, Boggess JF, Gehrig PA.

J Minim Invasive Gynecol. 2011 Nov-Dec;18(6):720-5. doi: 10.1016/j.jmig.2011.07.002. Epub 2011 Aug 15.

PMID:
21840773
24.

Robotic surgical training program in gynecology: how to train residents and fellows.

Geller EJ, Schuler KM, Boggess JF.

J Minim Invasive Gynecol. 2011 Mar-Apr;18(2):224-9. doi: 10.1016/j.jmig.2010.11.003. Epub 2011 Jan 22.

PMID:
21262591
25.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'Olio V, Peterlongo P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH, Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Sunde L, Cruger D, Birk Jensen U, Caligo M, Friedman E, Kaufman B, Laitman Y, Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernström H, Lindblom A, Rantala J, Stenmark-Askmalm M, Melin B; SWE-BRCA, Nathanson K, Domchek S, Jakubowska A, Lubinski J, Huzarski T, Osorio A, Lasa A, Durán M, Tejada MI, Godino J, Benitez J, Hamann U, Kriege M, Hoogerbrugge N, van der Luijt RB, van Asperen CJ, Devilee P, Meijers-Heijboer EJ, Blok MJ, Aalfs CM, Hogervorst F, Rookus M; HEBON, Cook M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ, Porteous ME, Walker L, Kennedy MJ, Dorkins H, Peock S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, de Pauw A, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Faivre L; GEMO, Loustalot C, Noguchi T, Sobol H, Rouleau E, Nogues C, Frénay M, Vénat-Bouvet L; GEMO, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D; Breast Cancer Family Registry, Singer CF, Dressler AC, Gschwantler-Kaulich D, Pfeiler G, Hansen TV, Jønson L, Agnarsson BA, Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov E, Tihomirova L, Blanco I, Lazaro C, Ramus SJ, Sucheston L, Karlan BY, Gross J, Schmutzler R, Wappenschmidt B, Engel C, Meindl A, Lochmann M, Arnold N, Heidemann S, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Kast K, Schönbuchner I, Caldes T, de la Hoya M, Aittomäki K, Nevanlinna H, Simard J, Spurdle AB, Holland H, Chen X; kConFab, Platte R, Chenevix-Trench G, Easton DF; CIMBA.

Cancer Res. 2010 Dec 1;70(23):9742-54. doi: 10.1158/0008-5472.CAN-10-1907. Epub 2010 Nov 30.

26.

Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment.

Bae-Jump VL, Zhou C, Boggess JF, Whang YE, Barroilhet L, Gehrig PA.

Gynecol Oncol. 2010 Dec;119(3):579-85. doi: 10.1016/j.ygyno.2010.08.025. Epub 2010 Sep 21.

27.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.

Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D; EMBRACE, Peock S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R, Izatt L, Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D, Houdayer C, Mazoyer S, Giraud S, Lasset C, Remenieras A, Caron O, Hardouin A, Berthet P; GEMO Study Collaborators, Hogervorst FB, Rookus MA, Jager A, van den Ouweland A, Hoogerbrugge N, van der Luijt RB, Meijers-Heijboer H, Gómez García EB; HEBON, Devilee P, Vreeswijk MP, Lubinski J, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Górski B, Cybulski C, Spurdle AB, Holland H; kConFab, Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Preisler-Adams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL, Rebbeck T, Blum JL, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R, Andrulis IL, Glendon G, Ozcelik H, Kirchhoff T, Vijai J, Gaudet MM, Altshuler D, Guiducci C; SWE-BRCA, Loman N, Harbst K, Rantala J, Ehrencrona H, Gerdes AM, Thomassen M, Sunde L, Peterlongo P, Manoukian S, Bonanni B, Viel A, Radice P, Caldes T, de la Hoya M, Singer CF, Fink-Retter A, Greene MH, Mai PL, Loud JT, Guidugli L, Lindor NM, Hansen TV, Nielsen FC, Blanco I, Lazaro C, Garber J, Ramus SJ, Gayther SA, Phelan C, Narod S, Szabo CI; MOD SQUAD, Benitez J, Osorio A, Nevanlinna H, Heikkinen T, Caligo MA, Beattie MS, Hamann U, Godwin AK, Montagna M, Casella C, Neuhausen SL, Karlan BY, Tung N, Toland AE, Weitzel J, Olopade O, Simard J, Soucy P, Rubinstein WS, Arason A, Rennert G, Martin NG, Montgomery GW, Chang-Claude J, Flesch-Janys D, Brauch H; GENICA, Severi G, Baglietto L, Cox A, Cross SS, Miron P, Gerty SM, Tapper W, Yannoukakos D, Fountzilas G, Fasching PA, Beckmann MW, Dos Santos Silva I, Peto J, Lambrechts D, Paridaens R, Rüdiger T, Försti A, Winqvist R, Pylkäs K, Diasio RB, Lee AM, Eckel-Passow J, Vachon C, Blows F, Driver K, Dunning A, Pharoah PP, Offit K, Pankratz VS, Hakonarson H, Chenevix-Trench G, Easton DF, Couch FJ.

Nat Genet. 2010 Oct;42(10):885-92. doi: 10.1038/ng.669. Epub 2010 Sep 19.

28.

Screening for Cervical Cancer [Internet].

Hartmann KE, Hall SA, Nanda K, Boggess JF, Zolnoun D.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Jan.

29.

Utility of the omentum in pelvic floor reconstruction following resection of anorectal malignancy: patient selection, technical caveats, and clinical outcomes.

Hultman CS, Sherrill MA, Halvorson EG, Lee CN, Boggess JF, Meyers MO, Calvo BA, Kim HJ.

Ann Plast Surg. 2010 May;64(5):559-62. doi: 10.1097/SAP.0b013e3181ce3947.

PMID:
20395804
30.

Efficacy and safety of imatinib mesylate (Gleevec) and immunohistochemical expression of c-Kit and PDGFR-beta in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus.

Huh WK, Sill MW, Darcy KM, Elias KM, Hoffman JS, Boggess JF, Alvarez RD, Long HJ, O'Malley DM, Birrer MJ.

Gynecol Oncol. 2010 May;117(2):248-54. doi: 10.1016/j.ygyno.2010.01.002. Epub 2010 Feb 26.

PMID:
20189232
31.

Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience.

Cantrell LA, Mendivil A, Gehrig PA, Boggess JF.

Gynecol Oncol. 2010 May;117(2):260-5. doi: 10.1016/j.ygyno.2010.01.012. Epub 2010 Feb 13.

PMID:
20153886
32.

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, Gómez García EB, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J; CMBA.

Br J Cancer. 2009 Dec 15;101(12):2048-54. doi: 10.1038/sj.bjc.6605416. Epub 2009 Nov 17.

33.

Perioperative outcomes of robotically assisted hysterectomy for benign cases with complex pathology.

Boggess JF, Gehrig PA, Cantrell L, Shafer A, Mendivil A, Rossi E, Hanna R.

Obstet Gynecol. 2009 Sep;114(3):585-93. doi: 10.1097/AOG.0b013e3181b47030.

PMID:
19701039
34.

Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis.

Shafer A, Zhou C, Gehrig PA, Boggess JF, Bae-Jump VL.

Int J Cancer. 2010 Mar 1;126(5):1144-54. doi: 10.1002/ijc.24837.

35.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, Ozcelik H, Glendon G; OCGN, Gerdes AM, Thomassen M, Sunde L, Caligo MA, Laitman Y, Kontorovich T, Cohen S, Kaufman B, Dagan E, Baruch RG, Friedman E, Harbst K, Barbany-Bustinza G, Rantala J, Ehrencrona H, Karlsson P, Domchek SM, Nathanson KL, Osorio A, Blanco I, Lasa A, Benítez J, Hamann U, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE; HEBON, Peock S, Cook M, Frost D, Oliver C, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Cole T, Hodgson S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, Buecher B, Léoné M, Bressac-de Paillerets B, Remenieras A, Caron O, Lenoir GM, Sevenet N, Longy M, Ferrer SF, Prieur F; GEMO, Goldgar D, Miron A, John EM, Buys SS, Daly MB, Hopper JL, Terry MB, Yassin Y; Breast Cancer Family Registry, Singer C, Gschwantler-Kaulich D, Staudigl C, Hansen Tv, Barkardottir RB, Kirchhoff T, Pal P, Kosarin K, Offit K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Suttner C, Schönbuchner I, Gadzicki D, Caldes T, de la Hoya M, Pooley KA, Easton DF, Chenevix-Trench G; CIMBA.

Hum Mol Genet. 2009 Nov 15;18(22):4442-56. doi: 10.1093/hmg/ddp372. Epub 2009 Aug 5.

36.

Emergence of robotic assisted surgery in gynecologic oncology: American perspective.

Mendivil A, Holloway RW, Boggess JF.

Gynecol Oncol. 2009 Aug;114(2 Suppl):S24-31. doi: 10.1016/j.ygyno.2009.02.002. Review.

PMID:
19573702
37.

Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.

Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA.

Cancer. 2009 Sep 1;115(17):3887-96. doi: 10.1002/cncr.24431.

38.
39.

A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy.

Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, Fowler WC.

Am J Obstet Gynecol. 2008 Oct;199(4):360.e1-9. doi: 10.1016/j.ajog.2008.08.012.

PMID:
18928974
40.

A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy.

Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, Fowler WC.

Am J Obstet Gynecol. 2008 Oct;199(4):357.e1-7. doi: 10.1016/j.ajog.2008.06.058.

PMID:
18928973
41.

Robotic-assisted endometrial cancer staging and radical hysterectomy with the da Vinci surgical system.

Shafer A, Boggess JF.

Gynecol Oncol. 2008 Nov;111(2 Suppl):S18-23. doi: 10.1016/j.ygyno.2008.07.023. Epub 2008 Sep 3.

PMID:
18771796
42.

What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?

Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF.

Gynecol Oncol. 2008 Oct;111(1):41-5. doi: 10.1016/j.ygyno.2008.06.030. Epub 2008 Aug 9.

PMID:
18694588
43.

Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Spriggs DR, Brady MF, Vaccarello L, Clarke-Pearson DL, Burger RA, Mannel R, Boggess JF, Lee RB, Hanly M.

J Clin Oncol. 2007 Oct 1;25(28):4466-71.

PMID:
17906207
44.

Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.

Zhou C, Boggess JF, Bae-Jump V, Gehrig PA.

Gynecol Oncol. 2007 Apr;105(1):218-22. Epub 2007 Feb 2.

PMID:
17275888
45.

Robotic surgery in gynecologic oncology: evolution of a new surgical paradigm.

Boggess JF.

J Robot Surg. 2007;1(1):31-7. doi: 10.1007/s11701-007-0011-4. Epub 2007 Feb 28. Review.

46.

Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.

Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA, Whang YE.

Gynecol Oncol. 2006 Nov;103(2):417-24. Epub 2006 May 11.

PMID:
16690106
47.

The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.

Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF.

Gynecol Oncol. 2006 May;101(2):305-10. Epub 2005 Dec 27.

PMID:
16380156
48.

Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.

Bae-Jump VL, Zhou C, Gehrig PA, Whang YE, Boggess JF.

Gynecol Oncol. 2006 Mar;100(3):487-94. Epub 2005 Oct 24.

PMID:
16249016
49.

EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma.

Livasy CA, Reading FC, Moore DT, Boggess JF, Lininger RA.

Gynecol Oncol. 2006 Jan;100(1):101-6. Epub 2005 Sep 12.

PMID:
16157366
50.

The use of non-nutritive sucking to decrease the physiologic pain response during neonatal circumcision: a randomized controlled trial.

South MM, Strauss RA, South AP, Boggess JF, Thorp JM.

Am J Obstet Gynecol. 2005 Aug;193(2):537-42; discussion 542-3.

PMID:
16098887

Supplemental Content

Loading ...
Support Center